Salix Coronary Plaque vs SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Salix Coronary Plaque

by Artrya Limited

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

by DIACOUSTIC MEDICAL DEVICES (PTY)

AI Verdict

Tool A, Salix Coronary Plaque, focuses on analyzing CCTA scans to detect and quantify coronary artery plaque and stenosis, aiding in the diagnosis of coronary artery disease. Tool B, SensiCardiac Mobi, is an AI-powered mobile application that assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope. While both are cardiology AI tools, their distinct input data (CCTA scans vs. heart sounds) and diagnostic targets (plaque/stenosis vs. heart murmurs) make them adjacent rather than direct competitors.

Choose Salix Coronary Plaque if…

Choose Salix Coronary Plaque if you need an AI-driven, near real-time assessment of coronary artery plaque and stenosis from CCTA scans. This tool is ideal for cardiologists and radiologists seeking to rapidly and accurately diagnose coronary artery disease, identify high-risk plaque features, and quantify calcifications for comprehensive patient evaluation.

View Salix Coronary Plaque →

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if…

Choose SensiCardiac Mobi if you require an AI-powered mobile application to assist in the diagnosis of heart murmurs by analyzing acoustic heart signals from an electronic stethoscope. This tool is best suited for physicians in cardiology, internal medicine, and pediatrics who need to differentiate between physiological and pathological heart sounds at the point of care.

View SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Salix Coronary Plaque	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION
Pricing	Contact for pricing	Contact for pricing
Deployment	Cloud	Hosted server environment (Linux OS) with a mobile application interface
BAA Available	Unknown	Yes AI-estimated
FDA Status	Yes AI-estimated	1 AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Salix Coronary Plaque

Tool A (Salix Coronary Plaque) is a web-based application designed for rapid, point-of-care assessment, emphasizing an intuitive interface and streamlined workflow to reduce unnecessary clicks and integrate with existing systems. Tool B (SensiCardiac Mobi) is a mobile application that relies on a user-provided electronic stethoscope and has received mixed user feedback regarding connectivity, loud alarms, and reliance on the phone.

Clinical Value

Salix Coronary Plaque

Tool A (Salix Coronary Plaque) provides comprehensive, near real-time analysis of CCTA scans for various plaque features, including high-risk plaque, which is a significant predictor of heart attacks often missed by traditional methods. Tool B (SensiCardiac Mobi) assists in differentiating physiological and pathological heart murmurs, which is a valuable diagnostic aid, but its scope is narrower compared to the detailed plaque analysis offered by Tool A.

Pricing & Value

Salix Coronary Plaque

Tool A (Salix Coronary Plaque) has a clear per-scan assessment model with a US CPT reimbursement rate of US$950, providing a transparent revenue opportunity for healthcare providers. Tool B (SensiCardiac Mobi) states 'contact for pricing' and 'not available publicly' for pricing details, making it difficult to assess its value proposition without further information.

Enterprise Readiness

Salix Coronary Plaque

Tool A (Salix Coronary Plaque) is a cloud-based, web application that integrates into existing CCTA workflows, aiming to streamline diagnosis, reduce costs, and handle growing demand without additional staff. Tool B (SensiCardiac Mobi) is a mobile application with a hosted server environment, which may present different integration challenges and scalability considerations for large enterprise deployments compared to a dedicated web-based platform.

Innovation

Salix Coronary Plaque

Tool A (Salix Coronary Plaque) offers advanced AI-driven analysis of CCTA scans to detect and quantify high-risk plaque features, which are often difficult to identify with traditional methods and are crucial for predicting future cardiac events. Tool B (SensiCardiac Mobi) utilizes AI for heart murmur analysis, which is innovative for a mobile application, but the detailed plaque characterization of Tool A represents a more novel approach to non-invasive cardiac risk assessment.

Support & Docs

Tie

Neither the provided structured facts nor the web search results offer specific details about the ongoing support, documentation, or training programs for either Tool A or Tool B. Therefore, it is not possible to definitively pick a winner in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Salix Coronary Plaque	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION
Tool Name	Salix Coronary Plaque	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION
Description	FDA-cleared, AI-driven, web-based software for near real-time, point-of-care assessment of coronary artery plaque and stenosis from CCTA scans, aiding in rapid and accurate diagnosis of coronary artery disease.	FDA-cleared AI-powered mobile application that assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope to differentiate between physiological and pathological sounds.
Company	Artrya Limited	DIACOUSTIC MEDICAL DEVICES (PTY)
Key Features	AI-enabled CCTA analysis, Near real-time, point-of-care assessment, Detection and quantification of coronary plaque (atherosclerosis), Identification of high-risk plaque features, Stenosis assessment, Quantification of calcifications (calcium scoring), Integrated workflow management, Automated report generation (editable).	Acquires and records acoustic heart signals, Analyzes heart sounds using the Sensi Diagnostic Heart Murmur Algorithm, Distinguishes between normal/physiological and pathological heart murmurs, Identifies S1, S2, and suspected murmurs, Records heart sounds at four main auscultation positions, Mobile application for data capture and display (e.g., iPhone 4S or later), Requires a compatible electronic stethoscope (user-provided), Operates as a decision support software, complementing physician assessment.

Videos

Demos, reviews, and walkthroughs featuring Salix Coronary Plaque and SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and EHR systems, and what is the typical workflow impact for a physician?

Salix Coronary Plaque (Tool A) is a web-based software that integrates with existing hospital and imaging clinic systems like PACS and EMRs, streamlining CCTA analysis and reporting within a single interface. It aims to reduce manual processing time for CCTAs by 35-55 minutes per scan, allowing for quicker diagnosis and potentially more scans per day. SensiCardiac Mobi (Tool B) is a mobile application that captures acoustic heart signals using an electronic stethoscope. Its integration typically involves exporting findings or reports into the EHR, complementing the physician's assessment during a patient encounter.

What are the reported accuracy and sensitivity metrics for each tool, and for which specific clinical conditions are they most effective?

Salix Coronary Plaque (Tool A) is designed for the detection and quantification of coronary plaque and stenosis from CCTA scans, including high-risk plaque features, aiding in the diagnosis of coronary artery disease. While specific accuracy and sensitivity metrics for Salix Coronary Plaque are not provided in the given information, Artrya states its algorithm has been built from thousands of scans for impressive accuracy. SensiCardiac Mobi (Tool B) assists in differentiating physiological from pathological heart murmurs, identifying S1, S2, and suspected murmurs, with reported sensitivity of 84% and specificity of 84% for pathological murmurs compared to echocardiogram.

What is the expected learning curve for physicians and staff, and how quickly can a practice anticipate realizing clinical value from each tool?

Salix Coronary Plaque (Tool A) features an intuitive web-based interface requiring minimal user training, aiming for rapid assessment within 10 minutes of a CCTA scan. This rapid turnaround time is expected to accelerate the triage of chest pain patients and improve diagnostic efficiency. SensiCardiac Mobi (Tool B), as a mobile application, likely offers a relatively quick learning curve for point-of-care use, with usability studies indicating high satisfaction and improved usability compared to a previous PC version.

What additional security measures and audit-trail features do these tools offer to protect patient data and track usage beyond standard compliance?

Salix Coronary Plaque (Tool A) includes security features such as data encryption and role-based access control (RBAC), and audit logs. The system also records the time of image upload and clinician analysis for tracking. For SensiCardiac Mobi (Tool B), while it is HIPAA compliant and has a BAA, specific audit-trail features for tracking usage or diagnostic decisions are not explicitly detailed in the provided information.

What are the key considerations for deploying these tools across multiple clinical sites or within a larger healthcare system?

Salix Coronary Plaque (Tool A) is a cloud-based solution designed for seamless integration with existing imaging and patient management systems, making it suitable for rollout across hospital networks and cardiology practices. Its web-based nature and minimal hardware requirements simplify deployment. SensiCardiac Mobi (Tool B), being a mobile application, would require managing compatible electronic stethoscopes and mobile devices across multiple sites. The hosted server environment would also need to be considered for scalability and access.

In what clinical contexts or for which patient populations would each tool be most beneficial?

Salix Coronary Plaque (Tool A) is most beneficial for cardiologists and radiologists evaluating patients who have undergone CCTA for suspected or known coronary artery disease, especially for identifying high-risk plaque features often missed by traditional methods. It can help in the rapid triage of chest pain patients and in tailoring preventative therapies. SensiCardiac Mobi (Tool B) is ideal for physicians in cardiology, internal medicine, and pediatrics who need immediate, AI-assisted assessment of heart murmurs at the point of care using an electronic stethoscope, helping to differentiate between physiological and pathological sounds and potentially avoid unnecessary referrals.